---
title: Merck KGaA vs Sambi Pharma
slug_a: merck-kgaa
slug_b: sambipharma
site: cdmo
review_signal_gate: closed
canonical_path: /compare/merck-kgaa/sambipharma
---

# Merck KGaA vs Sambi Pharma

Side-by-side profile data from each company listing on this directory.

## Merck KGaA

- Profile: [/companies/merck-kgaa](/companies/merck-kgaa)

Merck KGaA — Recent coverage reports that Merck KGaA plans to sell its life science CDMO business to Lonza. The same coverage describes a new €300 million bioprocessing center in Daejeon, South Korea.

Services: 0. Modalities: 0. Indications: 0. Locations: 1. Certifications: 0. The strongest documented coverage currently appears in locations (1).

### Services

- Data not yet provided.

### Modalities

- Data not yet provided.

### Development capabilities

- Data not yet provided.

### Manufacturing capabilities

- Data not yet provided.

## Sambi Pharma

- Profile: [/companies/sambipharma](/companies/sambipharma)

Sambi Pharma — Sambi Pharma offers process research and development, manufacturing, and analytical quality control services, alongside Fmoc-amino acid and specialty chemical products. Listed facilities are in Hyderabad, India, including an IDA Mallapur works site.

Services: 3. Modalities: 0. Indications: 0. Locations: 2. Certifications: 0. The strongest documented coverage currently appears in services (3).

### Services

- Small Molecule Development & Manufacturing
- Process Development
- Quality Control Testing

### Modalities

- Data not yet provided.

### Development capabilities

- Data not yet provided.

### Manufacturing capabilities

- Data not yet provided.